Soy Protein beneficial for individuals with diabetes

April 28, 2008

Researchers followed 41 patients with type 2 diabetes for 4 years. Twenty patients consumed a diet of which the protein consisted of 35% animal protein, 35% Soy Protein and 30% vegetable protein. The other 21 patients ate a diet where the protein was 70% animal and 30% vegetable protein. All of the patients’ diets consisted of 0.8 g protein per kg body weight. The patients on Soy Protein had a significant drop of fasting blood sugar, total cholesterol, LDL-cholesterol, and triglycerides. Inflammatory C reactive protein decreased in the Soy group as did protein in the urine and urine creatinine levels. The Soy Protein improved inflammation in the blood vessels, blood fats, blood sugar, and kidney health. The study is published in the April 2008 issue of the journal Diabetes Care.

Fish Oil Capsules stabilize heart rhythm

In a study from Royal Adelaide Hospital in Australia comparing the effectiveness of Fish Oil Capsules to reduce electrical irritability in the heart muscle thus promoting normal rhythm in the hearts of patients with rhythm abnormalities it was found that Fish Oil Capsules did indeed stabilize the heart rhythm. Dr Glenn Young. Lead author of the study is quoted “This stabilizing effect may be the way in which fish oil reduces mortality in patients with coronary artery disease”.
Several important studies have reported a decrease in risk of sudden cardiac death or cardiac arrest with increased consumption of fish or Fish Oil Capsules, supporting the idea that fish oil likely has heart-rhythm stabilizing, or "anti-arrhythmic" properties. In this newly published study 26 patients suffering from a rapid abnormal heart rhythm called ventricular tachycardia that were having a cardiac defibrillator implanted consumed either 3 grams from Fish Oil Capsules or inactive placebo daily for 6 weeks .
With an initial electrophysiologic study, the researchers were able to trigger ventricular tachycardia with stimuli in all 26 patients. However after Fish Oil Capsule supplementation during a repeat electrophysiologic study, they could not trigger ventricular tachycardia in 42 percent of the Fish Oil Capsule group compared with just 7 percent in the placebo group. To lend stronger supportive evidence to the anti-arrhythmic benefits of Fish Oil supplementation, 42 percent of the fish oil group required more aggressive stimulation to trigger ventricular tachycardia, compared with 36 percent of the control group. Dr Young concludes that the research “strongly” supports the premise that fish and Fish Oil Capsules have heart-rhythm stabilizing effects. The study is published in the March 15, 2008 issue of the American Journal of Cardiology.